Janney Montgomery Scott LLC Mirum Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$24.92 - $30.02 $231,456 - $278,825	-9,288 Reduced 38.54%	14,812 $372,000
Q4 2023 Feb 07, 2024	BUY	$27.14 - $34.93 $140,449 - $180,762	5,175 Added 27.34%	24,100 $711,000
Q3 2023 Nov 08, 2023	BUY	$24.63 - $32.85 $23,398 - $31,207	950 Added 5.29%	18,925 $598,000
Q2 2023 Jul 26, 2023	BUY	$23.51 - $30.09 $2,351 - $3,009	100 Added 0.56%	17,975 $465,000
Q1 2023 Apr 28, 2023	SELL	$19.19 - $24.1 $8,635 - $10,845	-450 Reduced 2.46%	17,875 $429,000
Q4 2022 Feb 01, 2023	SELL	$17.59 - $23.83 $19,349 - $26,212	-1,100 Reduced 5.66%	18,325 $357,000
Q3 2022 Oct 25, 2022	BUY	$19.98 - $29.44 $53,946 - $79,488	2,700 Added 16.14%	19,425 $408,000
Q2 2022 Aug 03, 2022	BUY	$18.42 - $27.5 $57,102 - $85,250	3,100 Added 22.75%	16,725 $308,000
Q1 2022 May 04, 2022	BUY	$15.5 - $23.93 $211,187 - $326,046	13,625 New	13,625 $300,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.